Yildirim, M. E. Et Al. 2024. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. Journal of Oncology Pharmacy Practice .

Yildirim, M. E., Karadurmuş, N., Ökten, İ. N., Türk, H. M., Urakçı, Z., Arslan, Ç., ... Çelik, S.(2024). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. Journal of Oncology Pharmacy Practice .

Yildirim, Mahmut Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC," Journal of Oncology Pharmacy Practice , 2024

Yildirim, Mahmut E. Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." Journal of Oncology Pharmacy Practice , 2024

Yildirim, M. E. Et Al. (2024) . "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." Journal of Oncology Pharmacy Practice .

@article{article, author={Mahmut Emre Yildirim Et Al. }, title={Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC}, journal={Journal of Oncology Pharmacy Practice}, year=2024}